From the Journal of Nephrology
Background
There is evidence that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARB) may reduce cardiovascular (CV) risk in patients undergoing peritoneal dialysis (PD), but no studies have compared the effectiveness between these drug classes. In this observational cohort study, we compared the association of ARB vs. ACEI
Home
»
» Unlabelled
» Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients
Subscribe to:
Post Comments (Atom)
Post a Comment